Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.58 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.98 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.620EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.80 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used